From: A general modular framework for gene set enrichment analysis
 | Gene set | p-value |
---|---|---|
1 | breast_cancer_estrogen_signalling | 0.000 |
2 | cell_surface_receptor_linked_signal_transduction | 0.000 |
3 | insulin_signalling | 0.000 |
4 | p53_signalling | 0.000 |
5 | pparaPathway | 0.000 |
6 | VOXPHOS | 0.000 |
7 | RAP_UP | 0.000 |
8 | PROLIF_GENES | 0.000 |
9 | UPREG_BY_HOXA9 | 0.000 |
10 | cell_adhesion | 0.001 |
11 | CR_CAM | 0.001 |
12 | CR_DEATH | 0.001 |
13 | il2rbPathway | 0.001 |
14 | ST_Tumor_Necrosis_Factor_Pathway | 0.001 |
15 | tcrPathway | 0.001 |
16 | HTERT_UP | 0.001 |
17 | CBF_LEUKEMIA_DOWNING_AML | 0.001 |
18 | CR_SIGNALLING | 0.002 |
19 | ghPathway | 0.002 |
20 | ST_B_Cell_Antigen_Receptor | 0.002 |
21 | tpoPathway | 0.002 |
22 | GO_0005739 | 0.002 |
23 | LEU_UP | 0.002 |
24 | Cell_Cycle | 0.003 |
25 | GLUT_UP | 0.003 |
26 | FRASOR_ER_DOWN | 0.003 |
27 | ANDROGEN_UP_GENES | 0.003 |
28 | fmlppathway | 0.004 |
29 | hivnefPathway | 0.004 |
30 | biopeptidesPathway | 0.005 |
31 | cell_adhesion_molecule_activity | 0.005 |
32 | SIG_InsulinReceptorPathwayInCardiacMyocytes | 0.005 |
33 | ST_Integrin_Signaling_Pathway | 0.005 |
34 | drug_resistance_and_metabolism | 0.006 |
35 | ST_Differentiation_Pathway_in_PC12_Cells | 0.007 |
36 | gleevecPathway | 0.008 |
37 | DNA_DAMAGE_SIGNALLING | 0.009 |
38 | ST_ERK1_ERK2_MAPK_Pathway | 0.009 |
39 | mRNA_splicing | 0.010 |
40 | nfatPathway | 0.010 |
41 | HUMAN_CD34_ENRICHED_TF_JP | 0.010 |